Latest Articles

Latest Videos

Video List based on Category on Node Page

Latest Videos

Growing old leads to a growing number of health problems, including those that challenge our ability to see. Age-related macular degeneration (AMD) is a disease that -- until recently -- robbed the elderly of the ability to read, drive and see the faces of their loved ones. Thanks to the invention of OCT, doctors can catch the disease before vision is lost. And with the aid of new drugs, AMD...
Baruch Kuppermann discusses the limitations of anti-VEGF agents in the treatment of diabetic macular oedema and the role of inflammation in its pathogenesis. He also gives his views on how steroids can be incorporated into the treatment paradigm, which are supported by clinical evidence, and the disadvantages of steroid treatment.
The introduction of vascular endothelial growth factor (VEGF) inhibitors began a new era in the treatment of exudative age-related macular degeneration (ARMD). These drugs are effective at suppressing choroidal neovascularization (CNV) resulting in improvement or stabilization of visual acuity; however, the chronic nature of the disease require these drugs be administered periodically (usually...

Posterior Segment INSIGHTS

The touchOPHTHALMOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of ophthalmology:

Insight
Controversies in the Vascular Mechanisms of Glaucomatous Optic Nerve Disease  Syed Shoeb Ahmad, Ophthalmology Department, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia
Insight
Minimally Invasive Glaucoma Surgeries (MIGS) Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK
Insight
Novel therapeutic targets in wet AMD Katrina Mountfort, PhD, Freelance Medical Writer, York, UK